Report cover image

Asia Pacific Genetic Testing Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Publisher The Insight Partners
Published Jul 10, 2025
Length 192 Pages
SKU # TIP20415815

Description

The Asia Pacific genetic testing services market is projected to grow significantly, reaching an estimated US$ 2,550.10 million by 2031, up from US$ 728.38 million in 2023. This growth represents a compound annual growth rate (CAGR) of 17.0% from 2023 to 2031.

Executive Summary and Market Analysis

The genetic testing services market in the Asia Pacific (APAC) region is experiencing rapid expansion, driven by several factors including increased healthcare investments, advancements in technology, and heightened awareness of genetic disorders. Key countries such as China, India, Japan, and South Korea are witnessing a notable rise in demand for genetic testing, particularly in areas such as cancer diagnosis, prenatal screening, and the identification of rare genetic diseases. The growth of personalized medicine, alongside advancements in genomic research, is further propelling the market forward. Additionally, government initiatives aimed at improving healthcare infrastructure and promoting genetic research are expected to bolster ongoing market development. The presence of major industry players is also fostering innovation and enhancing accessibility within the region.

Market Segmentation Analysis

The genetic testing services market can be segmented based on service type, disease, and service provider.

1. Service Type: The market is divided into several categories, including predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, the predictive testing segment held the largest market share.
2. Disease: The market is also segmented by disease type, including cancer, cardiovascular diseases, metabolic diseases, and other conditions. The cancer segment was the largest contributor to the market in 2023.
3. Service Provider: The market is categorized by service provider type, which includes hospital-based laboratories, diagnostic laboratories, and other providers. Hospital-based laboratories accounted for the largest share of the market in 2023.

Market Outlook

The increasing prevalence of genetic diseases globally is a significant concern, as these conditions can severely impact health. Genetic diseases often present with uncommon symptoms and are frequently non-curable. Many of these diseases are rare and arise from mutations in individuals' genetic makeup. According to the World Health Organization (WHO) in 2021, approximately 10 out of every 1,000 individuals are affected by single-gene diseases, indicating that between 70 million and 80 million people worldwide are living with such conditions. The Global Genes organization has identified around 7,000 rare diseases and disorders, with new ones being discovered regularly.

Research from the University of Sheffield estimates that around 300 million people globally are affected by genetic diseases. A report from MJH Life Sciences in 2022 highlighted that approximately 300,000 newborns are diagnosed with sickle cell disease each year, representing about 5% of the global population.

In the Asia Pacific and Middle East regions, a significant number of individuals are diagnosed with genetic diseases, partly due to the prevalence of consanguineous marriages in many communities. Such marriages contribute to the rising incidence of genetic disorders, thereby increasing the demand for genetic testing services, which in turn drives market growth.

Country Insights

The Asia Pacific genetic testing services market includes several key countries: China, Japan, India, Australia, South Korea, and others. China held the largest market share in 2023.

In recent years, awareness of the benefits of genetic testing has significantly increased in China. The availability of direct-to-consumer (DTC) tests has improved convenience and accessibility, positively influencing market growth. Chinese scientists and authorities have emphasized the potential of genetic material in studying and treating diseases, developing pharmaceuticals, and understanding congenital disabilities.

According to a study titled Spotlight on Gene Therapy in China, published in July 2020, over 57 million individuals in China suffer from genetic diseases, with approximately 4 million new cancer cases reported annually. The Global Cancer Observatory reported a total of 4,568,754 cancer cases in China in 2020. Furthermore, an article published in February 2023 noted that around 20 million people in China are affected by rare diseases.

The shift from a one-child policy to a universal two-child policy in China is expected to increase the number of births, thereby enhancing the demand for newborn genetic testing. Additionally, the Precision Medicine Initiative, launched by the Chinese Academy of Sciences in 2016, aims to sequence over 100 million human genomes by 2030, with a budget of US$ 9.2 billion. In July 2021, BGI Group, a Chinese gene company, developed a prenatal test in collaboration with the military, which collects genetic data from millions of women for extensive research on traits and abnormalities such as Down syndrome. These factors are anticipated to significantly drive the growth of the genetic testing services market in China.

Company Profiles

Key players in the Asia Pacific genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific genetic testing services market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific genetic testing services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

192 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Asia Pacific Genetic Testing Services Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic Diseases
4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
4.2 Market Restraints
4.2.1 Social and Ethical Implications of Genetic Testing
4.2.2 Affordability of Genetic Services
4.3 Market Opportunities
4.3.1 Untapped Emerging Markets in Developing Countries
4.4 Future Trends
4.4.1 Artificial Intelligence-Powered Genetic Testing
4.5 Impact Analysis:
5. Genetic Testing Services Market – Asia Pacific Analysis
5.1 Asia Pacific Genetic Testing Services Market Revenue (US$ Million), 2021–2031
5.2 Asia Pacific Genetic Testing Services Market Forecast Analysis
6. Asia Pacific Genetic Testing Services Market Analysis – by Service Type
6.1 Predictive Testing
6.1.1 Overview
6.1.2 Predictive Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.2 Carrier Testing
6.2.1 Overview
6.2.2 Carrier Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.3 Prenatal Testing
6.3.1 Overview
6.3.2 Prenatal Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.4 New-born Screening
6.4.1 Overview
6.4.2 New-born Screening: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.5 Diagnostic Genetic Testing
6.5.1 Overview
6.5.2 Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7. Asia Pacific Genetic Testing Services Market Analysis – by Disease
7.1 Cancer
7.1.1 Overview
7.1.2 Cancer: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Cardiovascular Diseases
7.2.1 Overview
7.2.2 Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Metabolic Diseases
7.3.1 Overview
7.3.2 Metabolic Diseases: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.4 Other Diseases
7.4.1 Overview
7.4.2 Other Diseases: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8. Asia Pacific Genetic Testing Services Market Analysis – by Service Providers
8.1 Hospital-Based Laboratories
8.1.1 Overview
8.1.2 Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.2 Diagnostic Laboratories
8.2.1 Overview
8.2.2 Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.3 Other Service Providers
8.3.1 Overview
8.3.2 Other Service Providers: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9. Asia Pacific Genetic Testing Services Market – Country Analysis
9.1 Asia Pacific
9.1.1 Asia Pacific Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
9.1.1.1 Asia Pacific Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
9.1.1.2 China: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1.1.2.1 China: Asia Pacific Genetic Testing Services Market Share – by Service Type
9.1.1.2.2 China: Asia Pacific Genetic Testing Services Market Share – by Disease
9.1.1.2.3 China: Asia Pacific Genetic Testing Services Market Share – by Cancer Disease
9.1.1.2.4 China: Asia Pacific Genetic Testing Services Market Share – by Service Providers
9.1.1.3 Japan: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1.1.3.1 Japan: Asia Pacific Genetic Testing Services Market Share – by Service Type
9.1.1.3.2 Japan: Asia Pacific Genetic Testing Services Market Share – by Disease
9.1.1.3.3 Japan: Asia Pacific Genetic Testing Services Market Share – by Cancer Disease
9.1.1.3.4 Japan: Asia Pacific Genetic Testing Services Market Share – by Service Providers
9.1.1.4 India: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1.1.4.1 India: Asia Pacific Genetic Testing Services Market Share – by Service Type
9.1.1.4.2 India: Asia Pacific Genetic Testing Services Market Share – by Disease
9.1.1.4.3 India: Asia Pacific Genetic Testing Services Market Share – by Cancer Disease
9.1.1.4.4 India: Asia Pacific Genetic Testing Services Market Share – by Service Providers
9.1.1.5 Australia: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1.1.5.1 Australia: Asia Pacific Genetic Testing Services Market Share – by Service Type
9.1.1.5.2 Australia: Asia Pacific Genetic Testing Services Market Share – by Disease
9.1.1.5.3 Australia: Asia Pacific Genetic Testing Services Market Share – by Cancer Disease
9.1.1.5.4 Australia: Asia Pacific Genetic Testing Services Market Share – by Service Providers
9.1.1.6 South Korea: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1.1.6.1 South Korea: Asia Pacific Genetic Testing Services Market Share – by Service Type
9.1.1.6.2 South Korea: Asia Pacific Genetic Testing Services Market Share – by Disease
9.1.1.6.3 South Korea: Asia Pacific Genetic Testing Services Market Share – by Cancer Disease
9.1.1.6.4 South Korea: Asia Pacific Genetic Testing Services Market Share – by Service Providers
9.1.1.7 Rest of APAC: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1.1.7.1 Rest of APAC: Asia Pacific Genetic Testing Services Market Share – by Service Type
9.1.1.7.2 Rest of APAC: Asia Pacific Genetic Testing Services Market Share – by Disease
9.1.1.7.3 Rest of APAC: Asia Pacific Genetic Testing Services Market Share – by Cancer Disease
9.1.1.7.4 Rest of APAC: Asia Pacific Genetic Testing Services Market Share – by Service Providers
10. Genetic Testing Services Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies in Genetic Testing Services Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eurofins Scientific SE
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Exact Sciences Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Laboratory Corp of America Holdings
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4andMe Holding Co
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Ambry Genetics Corp
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Quest Diagnostics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Illumina Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 F. Hoffmann-La Roche Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 NeoGenomics Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Centogene NV
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Ancestry Genomics Inc
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Gene By Gene Ltd
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Products and Services
11.12.4 Financial Overview
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 SIVOTEC BioInformatics LLC
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Products and Services
11.13.4 Financial Overview
11.13.5 SWOT Analysis
11.13.6 Key Developments
11.14 Progenesis
11.14.1 Key Facts
11.14.2 Business Description
11.14.3 Products and Services
11.14.4 Financial Overview
11.14.5 SWOT Analysis
11.14.6 Key Developments
11.15 Fulgent Genetics, Inc
11.15.1 Key Facts
11.15.2 Business Description
11.15.3 Products and Services
11.15.4 Financial Overview
11.15.5 SWOT Analysis
11.15.6 Key Developments
11.16 VERITAS INTERCONTINENTAL
11.16.1 Business Description
11.16.2 Products and Services
11.16.3 Financial Overview
11.16.4 SWOT Analysis
11.16.5 Key Developments
11.17 GeneDx, LLC
11.17.1 Key Facts
11.17.2 Business Description
11.17.3 Products and Services
11.17.4 Financial Overview
11.17.5 SWOT Analysis
11.17.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Genetic Testing Services Market Segmentation
Table 2. Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Table 3. Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Type
Table 4. Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease
Table 5. Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Providers
Table 6. Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
Table 7. China: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 8. China: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 9. China: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 10. China: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
Table 11. Japan: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 12. Japan: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 13. Japan: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 14. Japan: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
Table 15. India: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 16. India: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 17. India: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 18. India: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
Table 19. Australia: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 20. Australia: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 21. Australia: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 22. Australia: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
Table 23. South Korea: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 24. South Korea: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 25. South Korea: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 26. South Korea: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
Table 27. Rest of APAC: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 28. Rest of APAC: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 29. Rest of APAC: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 30. Rest of APAC: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
Table 31. Recent Organic Growth Strategies in Genetic Testing Services Market
Table 32. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
Table 33. Glossary of Terms, Genetic Testing Services Market

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us